Nifty 50
Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
ASTRAZEN
₹8,115
₹7900.00
₹8160.00
₹7551.50
₹9849.50
Markets Today
Historical Performance
As of 10-07-2026 20:25, AstraZeneca Pharma India Ltd. share price today is ₹0, with a change of ₹-8114.50 (-100.00%) from the previous close of ₹8114.5. The stock opened at ₹8100.5 and traded between ₹7900 and ₹8160, with a total traded volume of 5509 shares. The company has a market capitalization of ₹20286.2 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹9849.5 and ₹7551.5, respectively.
AstraZeneca Pharma India Ltd. valuation metrics include a P/E ratio of 108.2, and book value of ₹23.20. Profitability indicators show ROE of 21.48% along with a dividend yield of 0.4%. AstraZeneca Pharma India Ltd. has reported revenue of ₹2275.58 Cr and net profit of ₹187.52 Cr.
AstraZeneca Pharma India Ltd. technical indicators include Day RSI at 40.34, Day MFI at 29.55, Day ADX at 11.32. Additional indicators include Commodity Channel Index (CCI) at -99 and Williams %R at -82.4. Momentum indicators show Day MACD at -86.08, Day MACD Signal Line at -65.11, DayATR at 203.32. Rate of Change indicators for AstraZeneca Pharma India Ltd. include ROC125 at -5.66 and ROC21 at -4.
Exponential moving averages include EMA5 at ₹8176.2, EMA10 at ₹8229.1, EMA12 at ₹8247.4, EMA20 at ₹8304.7, EMA26 at ₹8333.4, EMA50 at ₹8393.1, EMA100 at ₹8473, EMA200 at ₹8516.1. Simple moving averages include SMA5 at ₹8201.2, SMA10 at ₹8210, SMA20 at ₹8325.2, SMA30 at ₹8399.3, SMA50 at ₹8431.6, SMA100 at ₹8474.4, SMA150 at ₹8562.6, SMA200 at ₹8715.1.
Support levels for AstraZeneca Pharma are placed at First Support ₹8067.33, Second Support ₹8020.17, Third Support ₹7939.33. Resistance levels are seen at First Resistance ₹8195.33, Second Resistance ₹8276.17, Third Resistance ₹8323.33. AstraZeneca Pharma India Ltd. shareholding pattern shows promoter holding at 75%, FII holding at 2.78%, DII holding at 0%, public holding at 16.42%.
Indicator | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
|---|---|---|---|---|---|
| Total Revenue | 578.61 | 611.57 | 559.09 | 526.31 | 480.48 |
| Operating Expense | 517.70 | 566.74 | 483.91 | 445.20 | 394.11 |
| Operating Profit | 60.91 | 44.83 | 75.18 | 81.11 | 86.37 |
| Depreciation | 5.60 | 3.84 | 2.57 | 16.57 | 17.69 |
| Interest | 2.04 | 1.06 | 0.67 | 0.72 | 0.68 |
| Tax | 13.26 | 13.95 | 18.60 | 18.87 | 20.22 |
| Net Profit | 44.88 | 32.59 | 54.22 | 55.83 | 58.25 |
₹8115.00
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Promoter | 75 | 75 | 75 | 75 | 75 | 75 |
| FII | 2.9 | 2.9 | 3 | 2.7 | 2.7 | 2.8 |
| DII | 5.2 | 4.6 | 4.6 | 5.3 | 5.6 | 5.8 |
| Public | 16.8 | 17.4 | 17.4 | 17 | 16.7 | 16.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.87 K | 2.93 K | 63.75% |
| Week | 1.99 K | 3.6 K | 55.13% |
| 1 Month | 3.85 K | 7.09 K | 54.23% |
| 6 Month | 4.35 K | 9.11 K | 47.73% |
Companies with no Debt
Benjamin Graham Value Screen
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
Growth in Net Profit with increasing Profit Margin (QoQ)
Book Value per share Improving for last 2 years
Companies with Zero Promoter Pledge
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 18 Jul, 2025 | 32 | FINAL | 18 Jul, 2025 | Equity Share |
| 05 Jul, 2024 | 24 | FINAL | 05 Jul, 2024 | Equity Share |
| 14 Jul, 2023 | 16 | FINAL | 14 Jul, 2023 | Equity Share |
| 07 Jul, 2022 | 8 | FINAL | 08 Jul, 2022 | Equity Share |
| 18 Aug, 2021 | 2 | INTERIM | 20 Aug, 2021 | Equity Share |
| 20 Aug, 2020 | 2 | INTERIM | 21 Aug, 2020 | Equity Share |
| 20 Aug, 2019 | 1 | INTERIM | 21 Aug, 2019 | Equity Share |
| 09 Jul, 2012 | 3.5 | FINAL | Equity Share | |
| 07 Jul, 2011 | 10 | FINAL | Equity Share | |
| 06 May, 2010 | 10 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,429 | ₹754.95 | ₹1,265 | ₹1,805 | ₹2,523 | ₹176.50 |
| % Change | 1.55% | 0.39% | 2.48% | -0.25% | -0.36% | 2.62% |
| Revenue TTM (₹ Cr) | ₹1,753.96 | ₹2,124.33 | ₹2,192.49 | ₹9,203.54 | ₹14,277.64 | ₹8,869.07 |
| Net Profit TTM (₹ Cr) | ₹246.74 | ₹591.79 | ₹348.91 | ₹924.36 | ₹1,912.93 | ₹-325.93 |
| PE TTM | 94.30 | 71.60 | 75.10 | 37.10 | 54.70 | -70.30 |
| 1 Year Return | 190.14 | 31.93 | 57.98 | 43.82 | 0.21 | -14.62 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Acutaas Chemicals Ltd.
₹ 3390.00
-1.99%
Gland Pharma Ltd.
₹ 2475.00
+0.22%
Laurus Labs Ltd.
₹ 1535.50
+1.86%
Alkem Laboratories Ltd.
₹ 5676.00
+0.49%
Biocon Ltd.
₹ 418.25
+3.64%
Divi's Laboratories Ltd.
₹ 6830.50
+0.26%
Granules India Ltd.
₹ 887.00
+0.56%
Ajanta Pharma Ltd.
₹ 3366.00
+1.77%
Zydus Lifesciences Ltd.
₹ 1152.10
-0.60%
Glenmark Pharmaceuticals Ltd.
₹ 2284.50
+0.76%
Wockhardt Ltd.
₹ 1812.80
-1.01%
Aurobindo Pharma Ltd.
₹ 1568.90
-1.17%
Sun Pharmaceutical Industries Ltd.
₹ 1932.90
-0.30%
Neuland Laboratories Ltd.
₹ 19478.00
-0.33%
Ipca Laboratories Ltd.
₹ 1780.10
+0.55%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2420.00
-1.00%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2433.00
-0.30%
Pfizer Ltd.
₹ 4720.00
+2.83%
Abbott India Ltd.
₹ 27340.00
+2.13%
Torrent Pharmaceuticals Ltd.
₹ 4890.00
-0.17%
Lupin Ltd.
₹ 2496.00
-0.29%
Dr. Reddy's Laboratories Ltd.
₹ 1246.90
-1.78%
Cipla Ltd.
₹ 1442.00
+0.05%
By signing up I certify terms, conditions & privacy policy